Search Results - "McDevitt, Susanne"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Clinical application of risk assessment in PAH: Expert center APRN recommendations by Wilson, Melisa, Keeley, Jennifer, Kingman, Martha, McDevitt, Susanne, Brewer, Jacqueline, Rogers, Frances, Hill, Wendy, Rideman, Zachary, Broderick, Meredith

    Published in Pulmonary circulation (01-07-2022)
    “…Performing longitudinal and consistent risk assessments for patients with pulmonary arterial hypertension (PAH) is important to help guide treatment decisions…”
    Get full text
    Journal Article
  2. 2

    Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1 by Frantz, Robert P., MD, McDevitt, Susanne, RN, MSN, Walker, Susan, MS

    “…Background N-terminal pro–B-type natriuretic peptide (NT-proBNP) is a biomarker of disease severity in pulmonary arterial hypertension (PAH). In this study we…”
    Get full text
    Journal Article
  3. 3

    Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations by Mathier, Michael A., MD, McDevitt, Susanne, RN, MSN, ACNP, Saggar, Rajan, MD

    “…Treprostinil, which is available for subcutaneous (SC) and intravenous (IV) administration, has demonstrated efficacy in increasing exercise capacity, reducing…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Abstract 57: Impact Of Body Mass Index In Functional Capacity And Hemodynamics In Patients With Pulmonary Arterial Hypertension by Munir, Rayyan, Meyyappan, Lakshmi, Liu, Emily, Kline-Rogers, Eva M, McDevitt, Susanne, Moles, Victor, McLaughlin, Vallerie

    “…Abstract only Background: Prior studies demonstrate a higher prevalence of pulmonary hypertension (PH) and more severe hemodynamics in patients with higher…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Abstract 56: Differences Between Chronic Thromboembolic Disease And Chronic Thromboembolic Pulmonary Hypertension Patients At Time Of Presentation by Hakim, Husain, Meyyappan, Lakshmi, Liu, Emily, Kline-Rogers, Eva M, McDevitt, Susanne, Moles, Victor, McLaughlin, Vallerie V

    “…Abstract only Background: Approximately 1/3 of acute pulmonary embolism (PE) patients develop chronic thromboembolic disease (CTED), a condition in which a…”
    Get full text
    Journal Article
  8. 8

    Abstract 193: Who Group III Pulmonary Hypertension Patients With Lower Socioeconomic Status Are Diagnosed at a Younger Age by Wasserman, Amanda, Morgan, Spencer, Weinstein, David, Neshewat, Julian, McDevitt, Susanne, Kline-Rogers, Eva, Cascino, Thomas, McLaughlin, Vallerie

    “…Abstract only Background: Previous research has shown that socioeconomic status (SES) is a contributing factor toward a patient’s health. Lower SES has been…”
    Get full text
    Journal Article
  9. 9

    Abstract 160: Comparison of Baseline Characteristics Among World Health Organization Groups in Pulmonary Hypertension by Neshewat, Julian M, Morgan, Spencer, Weinstein, David, Wasserman, Amanda, McDevitt, Susanne, Kline-Rogers, Eva, McLaughlin, Vallerie, Cascino, Thomas

    “…Abstract only Background: The epidemiology of pulmonary hypertension (PH) is changing with increasing numbers of patients diagnosed with non-group 1 pulmonary…”
    Get full text
    Journal Article
  10. 10
  11. 11